Pseudomyxoma peritonei: building a European multicentric cohort to accelerate new therapeutic perspectives (AWARD)

Prize: Prize (including medals and awards)

Description

A 5-year CRUK accelerator award to identify biomarkers and develop treatment options for patients with pseudomyxoma peritonei. Total Value=£3.5million. UK Component £1.2million
Awarded date1 Mar 2020
Degree of recognitionInternational
Granting OrganisationsCancer Research UK LTD

    Fingerprint